The mammalian target of rapamycin (mTOR) plays an important role in cell growth, proliferation, metabolism and angiogenesis. Currently, this protein has emerged as an attractive target for novel development of anticancer drugs. Meanwhile, significant progress has been made in hit discovery, lead compound optimization, drug candidate development and determination of the three-dimensional (3D) structure of mTOR. Scientists have established a series of computational methods to accelerate the discovery and development of mTOR inhibitors, including modeling the structure of mTOR, screening of compound databases, discovering structure-activity relationships (SAR) and optimizing hits, mining privileged fragments and designing library-focused libraries.
BOC Sciences is committed to designing a high-quality mTOR-targeted library to discover potential mTOR inhibitors.
Figure 1. mTOR complexes and their functional interacting partners. (Ismael Bracho, V.; et al. 2011)
Figure 1. mTORC1 and mTORC2 signaling networks. (Ismael Bracho, V.; et al. 2011)
BOC Sciences provides professional, rapid and high-quality services of mTOR-Targeted Library design at competitive prices for global customers. Personalized and customized services of mTOR-Targeted Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.